Anheuser-Busch InBev SA/NV (BUD) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$82.09
Price Target
$89.00
Target Range
$82.00 — $100.00
Analyst Rating
Buy
Forward P/E19.2x
Trailing P/E28.7x
Forward PEG—
Implied Growth-32.3%
Median Target$85.00
Analyst Spread20.2%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$82
-0.1%
Consensus
$89
+8.4%
Bull Case
$100
+21.8%
Valuation Model TargetsConfidence: 57/100
Bear$101
Base$181
Bull$258
BUD Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Anheuser-Busch InBev SA/NV (BUD) has a Wall Street consensus price target of $89.00, based on estimates from 45 covering analysts. With the stock currently trading at $82.09, this represents a potential upside of +8.4%. The company has a market capitalization of $141.26B.
Analyst price targets range from a low of $82.00 to a high of $100.00, representing a 20% spread in expectations. The median target of $85.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 26 analysts rating the stock as a Buy or Strong Buy,16 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BUD trades at a trailing P/E of 28.7x and forward P/E of 19.2x. Analysts expect EPS to grow -32.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $180.80, with bear and bull scenarios of $100.73 and $257.61 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Defensive stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+14.4%
Avg Forward P/E13.0x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 TAPMolson Coors Beverage Company | $8.0B | $42.76 | $48.30 | +13.0% | Hold | 9.1x | 37 |
 SAMThe Boston Beer Company, Inc. | $2.2B | $206.36 | $246.86 | +19.6% | Hold | 20.9x | 31 |
 ABEVAmbev S.A. | $53.6B | $3.43 | $2.84 | -17.2% | Hold | 3.4x | 14 |
 STZConstellation Brands, Inc. | $26.4B | $152.29 | $175.70 | +15.4% | Buy | 12.9x | 46 |
 DEODiageo plc | $47.0B | $84.58 | $124.00 | +46.6% | Hold | 18.1x | 35 |
 MGPIMGP Ingredients, Inc. | $413M | $19.32 | $29.00 | +50.1% | Buy | 12.2x | 14 |
 CCKCrown Holdings, Inc. | $11.3B | $101.09 | $120.50 | +19.2% | Buy | 12.5x | 25 |
 SEESealed Air Corporation | $6.2B | $42.15 | $43.50 | +3.2% | Buy | 12.4x | 27 |
 ADMArcher-Daniels-Midland Company | $37.6B | $78.02 | $60.00 | -23.1% | Hold | 18.7x | 36 |
 INGRIngredion Incorporated | $6.7B | $106.37 | $124.25 | +16.8% | Hold | 9.5x | 21 |
Upside Potential Comparison
MGPIDEOSAMCCKINGRSTZTAPSEEFull BUD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BUD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BUD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BUD vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonBUD — Frequently Asked Questions
Quick answers to the most common questions about buying BUD stock.
What is the BUD stock price target for 2026?
The consensus price target for BUD is $89, close to the current price of $82.092 (8.4% implied move). Based on 45 analyst estimates, the stock appears fairly valued near current levels.
Is BUD a buy, sell, or hold?
BUD has a consensus rating of "Buy" based on 45 Wall Street analysts. The rating breakdown is predominantly bullish, with 26 Buy/Strong Buy ratings. The consensus 12-month price target of $89 implies 8.4% upside from current levels.
Is BUD stock overvalued or undervalued?
With a forward P/E of 19.2384x, BUD trades at a relatively low valuation. The consensus target of $89 implies 8.4% appreciation, suggesting the market may be pricing in risks.
How high can BUD stock go?
The most bullish Wall Street analyst has a price target of $100 for BUD, while the most conservative target is $82. The consensus of $89 represents the median expectation. Our quantitative valuation model projects a bull case target of $258 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover BUD stock?
BUD is heavily covered by Wall Street, with 45 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 26 have Buy ratings, 16 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BUD stock forecast?
The 12-month BUD stock forecast based on 45 Wall Street analysts shows a consensus price target of $89, with estimates ranging from $82 (bear case) to $100 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $181, with bear/bull scenarios of $101/$258.
What is BUD's fair value based on fundamentals?
Our quantitative valuation model calculates BUD's fair value at $181 (base case), with a bear case of $101 and bull case of $258. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
What is BUD's forward P/E ratio?
BUD trades at a forward P/E ratio of 19.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BUD stock?
BUD appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $89 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BUD price targets vary so much?
BUD analyst price targets range from $82 to $100, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $89 consensus represents the middle ground. Our model's $101-$258 range provides an independent fundamental perspective.